UNSPSC 51152051: Cisatracurium besilate

This classification denotes a nicotinic antagonist with the molecular formula C53H72N2O12.2C6H5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80YS8O1MBS, chemically known as isoquinolinium, 2,2-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, (1r-(1alpha,2alpha(1r(sup *),2r(sup *))))- but more generally known as cisatracurium besilate, which bears US NIH Compound Identifier 62886.

UNSPSC 51152051 Cisatracurium besilate is a Commodity code that appears in state and local procurement records with minimal recent activity aligned to its nominal scope. The single recent opportunity tagged to this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and safe drug deactivation systems, not cisatracurium besilate (a neuromuscular blocking agent used in anesthesia). The mismatch suggests either a coding error in the posting or a secondary mention of pharmaceutical procurement that does not reflect the true substance of the work being acquired.

Absent additional recent opportunities properly coded to cisatracurium besilate, the summary cannot characterize the current market activity, issuing-body mix, or geographic spread for this Commodity under state and local procurement. A business development professional evaluating this code should verify coding accuracy in any future RFP or RFQ records and assess whether the pharmaceutical supply-chain activity (if any) that does use cisatracurium besilate is being tagged to a different or more precise UNSPSC code within the 51152000 pharmaceutical family.